428 Pharma develops a formulation of the worlds first long-acting injectable (LAI) for prevention of relapse in MDD with a potential time to market in 2028. 428 Pharma pursues a PK-only pathway under FDA 505(b)(2) development with LOE until 2046.
| Website | http://www.428pharma.com |
| Employees | 5 (1 on RocketReach) |
| Phone | +972 54-888-5275 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical Manufacturing, Pharmaceutical Research, Drug Discovery, Drug Development, Clinical Research, Clinical Trials, Medicinal Chemistry, Drug Delivery, Biotechnology, Life Sciences, Biopharma, Generic Drugs, Regulatory Affairs, Healthcare Solutions, Prescription Medications, Pharmaceutical Sales, Healthcare, Contract Manufacturing |
Looking for a particular 428 Pharma employee's phone or email?
428 Pharma Questions
Sofia Weirich is the CFO and Founding Investor of 428 Pharma.
1 people are employed at 428 Pharma.
Top 428 Pharma Employees
-
Sofia Weirich
CFO and Founding Investor at 428 Pharma
Munich, BY, DE11
Related Companies
G2Crowd Trusted
300K+
Plugin Users
